Carregant...
Hyperhomocysteinaemia and vascular injury: advances in mechanisms and drug targets
Homocysteine is a sulphur‐containing non‐proteinogenic amino acid. Hyperhomocysteinaemia (HHcy), the pathogenic elevation of plasma homocysteine as a result of an imbalance of its metabolism, is an independent risk factor for various vascular diseases, such as atherosclerosis, hypertension, vascular...
Guardat en:
| Publicat a: | Br J Pharmacol |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5867019/ https://ncbi.nlm.nih.gov/pubmed/28836260 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.13988 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|